Clinical trial
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
NCT03198546
Study timeline
Study start (actual)2017-07-01Date precision: day
Registry last updated2024-06-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hepatocellular Carcinomaunresolved
Immunotherapyunresolved
CARunresolved
GPC3 Gene Inactivationunresolved
T Cellunresolved
Squamous Cell Lung Cancerunresolved
Interventions
GPC3 and/or TGFβ targeting CAR-T cellsBIOLOGICAL
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03198546 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.